Clinical Trial Update: Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating OrbusNeich's Healthy Endothelial Accelerated Lining technology for coronary artery disease and coronary artery stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• Healthy Endothelial Accelerated Lining (HEAL) technology

Snippet

Sponsor: OrbusNeich | Conditions: Coronary Artery Disease, Coronary Artery Stenosis | Phase 4 | Status: COMPLETED